Author: Julie Kaloides

DAYTON, OH—CSafe Global, a leading provider of active and passive temperature-controlled packaging solutions for pharmaceutical products, is pleased to announce that American Airlines Cargo, one of the industry’s leading air cargo brands, has approved the recently launched CSafe RAP for flight.
CSafe Global recently launched its latest innovation in temperature-controlled active containers, the CSafe RAP. This new industry-leading solution offers unmatched operational performance, even in the most extreme ambient conditions (-30°C to +54°C), with proprietary VIP insulation, an innovative air recirculation technology, and a unique, autonomous temperature management system.
Since launch, international airlines have worked diligently to approve and qualify this new air-cargo container solution for use on their cargo fleet. Having already seen widespread use, the CSafe RAP has successfully managed numerous temperature-sensitive and time-critical shipments across the globe. Today, American Airlines is the latest airline to approve the CSafe RAP, enabling them to join the roster of airlines that offer the system to their life-science customers who transport large volumes of temperature-sensitive pharmaceutical products.
“We are very proud and excited to now have the validation approval from American Airlines for our CSafe RAP system,” states Jeff Pepperworth, Chief Executive Officer of CSafe Global. “We certainly look forward to further partnering with American to serve our joint pharma customers and to continue the expansion of our global reach with this new active temperature management offering.”
Tom Grubb, global head of pharmaceuticals and healthcare for American Airlines Cargo says “For many years, American and CSafe have worked together to provide high-quality, temperature-controlled Active RKNs to pharmaceutical and healthcare shippers who depend on these containers for safe air transport of their products. American’s goal is to ensure ExpediteTC° continues to accommodate customer requirements in order to meet future demand for increasingly complex medicines around the world. With this objective in mind, American is pleased to now offer the CSafe RAP as a key option for our customers’ valuable cargo.”
The CSafe RAP delivers best-in-class payload temperature protection for vital life-science shipments, assuring the safe delivery of temperature-sensitive, life-enhancing products to patients around the world.
Many of the same leasing options currently available for the proven CSafe RKN are also available for the new CSafe RAP container. Customers may lease the CSafe RAP container directly from CSafe Global, American Airlines, or through one of CSafe’s other logistics partners.
Customers seeking more information about the CSafe RAP or their leasing options should visit www.csafeglobal.com/product/csafe-rap.

BALTIMORE /PRNewswire/ — Great Place to Work^® Institute has recognized Senior Helpers^® as the first national in-home care company to achieve certification as a Great Place to Work. Senior Helpers’ rapidly growing business is laser-focused on helping older adults age with dignity, and the company cares for tens of thousands of seniors across the globe.
The Great Place to Work evaluation considers more than 60 elements of the team member experience using feedback from surveys sent to more than 12,000 employees across the country. The factors considered include the respect with which people are treated, employee pride and camaraderie, and the recognition that the work team members do makes a real difference for clients. Rankings are based on the experiences and perceptions of all employees and every role.
“This independent recognition is a very proud moment for Senior Helpers,” said Peter Ross, CEO and co-founder of Senior Helpers. “We understand that company culture is an important driver of overall success and we have worked diligently to build a culture of inclusion and appreciation. Our employees care deeply about our clients, and it brings us great joy to know that they feel recognized and appreciated for their work.”
Senior Helpers’ culture is based on strong core values, recognition of achievements and respect. The executive team receives monthly feedback from both clients and employees. “Our internal data has consistently been positive,” said Chuck Sullivan, CMO of Senior Helpers. “We are very pleased that we now have independent verification that shines a light on our rich culture and appreciation of Senior Helpers as a Great Place to Work.”
“We applaud Senior Helpers for seeking certification and releasing its employees’ feedback,” said Dr. Jacquelyn Kung, of Great Place to Work’s senior care affiliate Activated Insights.
“These high ratings measure Senior Helpers capacity to earn its employees’ trust and create a great workplace for high performance.”
The Great Place to Work Trust Index^TM methodology is taken by millions of employees in thousands of companies annually. It represents the gold standard in measuring culture and employee engagement.
About Senior Helpers^®
Senior Helpers is the nation’s premier provider of in-home senior services ranging from specialized care for those with diseases, such as dementia, Alzheimer’s and Parkinson’s, to personal and companion care to help individuals looking for a little assistance with daily activities. Founded in 2002 with a vision to help seniors age with dignity despite age-related illnesses and mobility challenges, Senior Helpers has hundreds of franchised and owned businesses that have cared for tens of thousands of seniors.

NASHVILLE, Tenn.—(BUSINESS WIRE)—Endpoint data loss, excessive user permissions, and dormant accounts make up 70 percent of all high and critical risk scenarios for laptop vulnerabilities at hospitals and health systems across the country, according to new findings released by the Clearwater CyberIntelligence Institute (CCI), which leverages insights from Clearwater’s proprietary database—the industry’s largest and most complete database focused exclusively on the unique cybersecurity risk profiles of hospitals, Integrated Delivery Networks (IDNs) and business associates.
Despite efforts to make laptops more secure, the CCI study found they remain a Top 10 cybersecurity risk for hospitals and health systems. Upon further study, CCI found that the No. 1 vulnerability among laptops — endpoint data loss — remains so high because of continued deficiencies in these important controls:

• 98.9 percent of laptops have deficiencies in locked down external ports (USB, CD, DVD, Firewire, etc.), which prevent users from exporting sensitive data to external storage media.
• 63.3 percent of laptops have deficiencies of users storing data locally rather than accessing the organization’s programs and data via secure, virtual desktop software (such as Citrix Virtual Apps, Desktop or VMWare Horizon).
• 52.7 percent have deficiencies in data loss prevention tools, which are designed to scan all communications traffic to keep sensitive data from being sent to unauthorized users.

“It may seem like a given, but the questions that hospitals and health systems need to be constantly considering are, do we know for certain that the security measures we have adopted for these things have been properly implemented,” said Clearwater’s Jon Stone, who leads CCI and serves as senior vice president for Product Innovation. “Further, do the risk ratings associated with these controls bring the right level of attention to these major risks?”
See the complete the findings and learn how to address these high-risk factors here.
About Clearwater CyberIntelligence™ Institute (CCI)
CCI harnesses the power of a database populated by healthcare organizations that contain millions of risk records from hospitals, Integrated Delivery Networks (IDNs) and business associates to safeguard patient safety and private organizations against cyber threats. Launched in 2018, CCI was established as a response to the exponentially growing threat surface from the Internet of Things and the proliferation of attackers in healthcare. The data mining and informatics team at the CCI institute uses advanced analytics techniques to provide useful publications to identify common security weaknesses found in hospitals, health systems and other healthcare organizations. Hospital executives can direct their immediate attention to threats, vulnerabilities and control deficiencies identified by CCI and perhaps take immediate action to reduce their organization’s risk profile.
About Clearwater
Clearwater provides the most complete and trusted, enterprise-class cyber risk management solution available. Designed for healthcare providers and their partners, Clearwater’s IRM|Pro™ platform and experienced professional services team provide insights and actions to address compliance, cyber and patient safety risks. Clearwater is a 2017 Inc. 5000 fastest-growing company, the 2018 Best in KLAS winner in Cybersecurity Advisory Services, the 2017 and 2018 Black Book Marketing Research winner in Compliance and Risk Management Solutions, and exclusively endorsed by the American Hospital Association as well as numerous state hospital associations. Clearwater solutions have been deployed within hundreds of hospitals and health systems, Fortune 100 organizations, and federal government institutions. More information about Clearwater is at clearwatercompliance.com.

NASHVILLE, Tenn.—(BUSINESS WIRE)—Clearwater and Digital Reasoning today announced a strategic three-year Cyber Risk Services partnership enabling healthcare providers to realize the results of artificial intelligence (AI) powered solutions supported by a proven and trusted cybersecurity and HIPAA compliance program.
Experts predict AI will dramatically impact the “Triple Aim” – cost, quality and patient experience – by creating value from patient data. With Patient Health Information (PHI) at the heart of that work, healthcare AI necessitates the highest standards in cybersecurity to ensure patient and provider confidence in their data safeguards.
As Clearwater supports many technology companies entering healthcare, such as Uber Health, the company’s work with Digital Reasoning couples its IRM|Pro™ Cyber Risk Management SaaS platform with professional service expertise to deliver an OCR-Quality Risk Analysis™. Clearwater’s Cyber Risk Services will support enablement of administrative, technical and physical safeguards combined with workforce training, policies and procedures.
“We are honored to earn the trust and confidence of Digital Reasoning and to join them in enabling this strategically important evolution in healthcare,” said Steve Cagle, Clearwater CEO. “Healthcare presents an important growth opportunity, and we are excited to support Digital Reasoning as they bring their proven AI technologies to the industry and to the benefit of millions of patients.”
With increasing pressure on health systems to create value from the digitization of medical records and build consumer-centric solutions comes increased necessity to ensure PHI is handled with the highest care and security.
“Clearwater’s deep experience with leading health systems and its ability to deliver the gold standard in cybersecurity beyond simply HIPAA compliance makes this a strong partnership that will benefit our current and future healthcare clients,” said Digital Reasoning CEO Brett Jackson. “AI and machine learning empowers solutions to extract value from healthcare organizations’ data. That only happens with the highest cybersecurity standards. Only together can we deliver on the promise of AI – augmenting doctors, nurses and the whole care team to enhance their most important work: caring for patients.”
Digital Reasoning, recognized by PitchBook in 2018 as Tennessee’s most valuable startup, began the healthcare journey by entering into a strategic partnership with HCA Healthcare to unlock valuable insights captured within both unstructured and structured data in clinical records. This partnership yielded proven, market-validated solutions that will now be available to all healthcare providers. Last year, the company announced a new, $30 million round of funding that included previous investor HCA.
About Digital Reasoning
Digital Reasoning builds software that understands human communication, context and meaning to create value at enterprise scale. In health care, Digital Reasoning deploys AI-powered care management software within health systems to augment the care team and accelerate the entire care process, delivering a positive impact on clinical, financial and operational outcomes. For more information about Digital Reasoning visit www.digitalreasoning.com/healthcare.
About Clearwater
Clearwater provides the most complete and trusted, enterprise-class cyber risk management solution available. Designed for healthcare providers and their partners, Clearwater’s IRM|Pro™ platform and experienced professional services team provide insights and actions to address compliance, cyber and patient safety risks. Clearwater is a 2017 Inc. 5000 fastest-growing company, the 2018 Best in KLAS winner in Cybersecurity Advisory Services, the 2017 and 2018 Black Book Marketing Research winner in Compliance and Risk Management Solutions, and exclusively endorsed by the American Hospital Association as well as numerous state hospital associations. Clearwater solutions have been deployed within hundreds of hospitals and health systems, Fortune 100 organizations, and federal government institutions. More information about Clearwater is at www.clearwatercompliance.com.

Montreal, Canada—Chemical Computing Group (CCG) and the American Chemical Society’s (ACS) Division of Computers in Chemistry (COMP) congratulate the winners of the COMP CCG Research Excellence Awards for the Spring 2019 ACS National Meeting in Orlando, FL.
The award winners’ research will be recognized at the COMP Division Poster Session on Tuesday, April 2nd, 2019. Each winner will receive an award certificate, a one-year MOE (Molecular Operating Environment) software license for the winners’ research group, as well as financial support to cover their travel costs to Orlando.
The winners are:
Vinicius Cruzeiro, University of Florida, group of Adrian E. Roitberg
Ryan DeFever, Clemson University, group of Sapna Sarupria
Hongxia Hao, Brown University, group of Brenda M. Rubenstein
Joonho Lee, University of California, Berkeley, group of Martin P. Head-Gordon
Fang-Yu Lin, University of Maryland, group of Alexander D. MacKerell
About COMP CCG Research Excellence Awards
The COMP CCG Research Excellence Awards recognize and encourage exceptional research conducted by graduate students in the field of computational chemistry. For more information about the CCG Excellence Awards, please visit: www.chemcomp.com/research-academic.htm
About Chemical Computing Group
CCG (Chemical Computing Group) is a leading supplier of software solutions for life sciences. With a proven track record in scientific innovation, CCG continues to provide state-of-the-art applications in drug discovery to pharmaceutical, biotechnology and academic researchers. CCG’s software platform is the Molecular Operating Environment (MOE) which is used by computational chemists, medicinal chemists and biologists in the major pharmaceutical and biotechnology companies throughout the world. CCG has a very strong reputation for collaborative scientific support, maintaining support offices in both Europe and North America. Founded in 1994, CCG is headquartered in Montreal, Canada. For more information visit: www.chemcomp.com

New York, NY: Altaris Capital Partners, LLC announces an investment in Community Pharmacy Partners (“CPP”).
CPP operates pharmacies in Texas, Arizona and Virginia that are focused on providing patients with safe and efficacious alternatives to prescription opioids for pain management. Altaris has partnered with the founders of CPP and its management team as part of a recapitalization transaction to support the company’s growth plans.
CPP is headquartered in Dallas, TX.For more information on CPP, visit www.communityrxp.com.

NASHVILLE, Tenn.—(BUSINESS WIRE)—The three most critical and common high-security cyber risks facing healthcare delivery organizations and their partners have been uncovered in a first-of-its-kind analysis by the Clearwater CyberIntelligence™ Institute (CCI). CCI was formed earlier this year to leverage insights from Clearwater’s proprietary database created by IRM|Analysis™. The database, containing millions of risk records accumulated during the completion of comprehensive, NIST-based risk analyses for hundreds of Clearwater customers over the last six years, is the industry’s largest and most complete database focused exclusively on the unique cybersecurity risk profiles of hospitals, Integrated Delivery Networks (IDNs) and business associates.
At the top of the patient data breach vulnerability list is User Authentication Deficiencies, followed by Endpoint Leakage and Excessive User Permissions, the CCI analysis revealed. Together, the top three areas of vulnerability account for nearly 37 percent of all critical risk scenarios.
“Hospital executives should direct their immediate attention to these three top vulnerabilities and consider action to reduce their organization’s risk profile,” said Clearwater’s Jon Stone, who leads CCI and serves as senior vice president for Product Innovation. “It is critically important that hospitals and health systems evaluate their organization’s information systems to determine their specific risk ratings on these three critical vulnerabilities and take the necessary steps to close any gaps.”
For context, User Authentication Deficiencies are weaknesses in the process used by an organization to uniquely identify and verify a user. Examples of deficiencies include such things as use of generic User IDs and/or passwords, posting user passwords on monitors or under keyboards, and emailing user credentials unencrypted over external networks. Some of the most common technology associated with these gaps include servers and SaaS (Software-as-a-Service) solutions. Complete findings can be found in the first edition of the Clearwater CyberIntelligence Insight Bulletin.
CCI was established earlier this year as a response to the exponentially growing threat surface from the Internet of Things (IoT) and the proliferation of attackers in healthcare. The data mining and informatics team at the Institute uses advanced analytics techniques to identify common security weaknesses found in hospitals, health systems and other healthcare organizations and provide actionable steps they can take to better protect themselves and their patient data from cyber attack. CCI leverages the enormous data set of cyber risk information stored in its proprietary IRM|Analysis™ database, which was built over the last six years from millions of risk records collected from hundreds of hospitals, Integrated Delivery Networks (IDNs) and business associates while completing comprehensive, NIST-based cybersecurity Risk Analyses.
“IRM|Analysis has become the industry’s gold standard for performing an OCR-Quality Risk Analysis, and with so many hospitals now using the software, we are accumulating an enormous amount of data,” noted Steve Cagle, CEO of Clearwater. “Clearwater will continue to leverage this data to provide insights and best practices to its Customers, as we continue to build upon reputation of thought leadership in risk analysis and cyber risk management.”
About Clearwater CyberIntelligence™ Institute (CCI)
CCI harnesses the power of a database populated by healthcare organizations that contain millions of risk records from hospitals, Integrated Delivery Networks (IDNs) and business associates to safeguard patient safety and private organizations against cyber threats. Launched in 2018, CCI was established as a response to the exponentially growing threat surface from the Internet of Things and the proliferation of attackers in healthcare. The data mining and informatics team at the CCI institute uses advanced analytics techniques to provide useful publications to identify common security weaknesses found in hospitals, health systems and other healthcare organizations. Hospital executives can direct their immediate attention to threats, vulnerabilities and control deficiencies identified by CCI and perhaps take immediate action to reduce their organization’s risk profile.
About Clearwater
Clearwater provides the most complete and trusted, enterprise-class cyber risk management solution available. Designed for healthcare providers and their partners, Clearwater’s IRM|Pro™ platform and experienced professional services team provide insights and actions to address compliance, cyber and patient safety risks. Clearwater is a 2017 Inc. 5000 fastest-growing company, the 2018 Best in KLAS winner in Cybersecurity Advisory Services, the 2017 and 2018 Black Book Marketing Research winner in Compliance and Risk Management Solutions, and exclusively endorsed by the American Hospital Association as well as numerous state hospital associations. Clearwater solutions have been deployed within hundreds of hospitals and health systems, Fortune 100 organizations, and federal government institutions. More information about Clearwater is at www.clearwatercompliance.com.

Franklin, Ind.—G&H Orthodontics, a leading provider of clinical solutions for the orthodontic community, today announced the appointment of John Voskuil as Chief Executive Officer.
Mr. Voskuil joins G&H with more than 20 years of experience delivering solutions to patients and doctors in the dental and orthodontics industry. Prior to G&H, Mr. Voskuil held a number of senior leadership positions at Dentsply Sirona and earned a Bachelor of Science in Industrial Technology Management from the University of Wisconsin – Platteville and an MBA from Northern Illinois University.
“I am thrilled to join the G&H Orthodontics team and continue the company’s strong history of providing industry leading quality and value to its customers and partners around the world,” said Mr. Voskuil. “With its globally recognized brand and world–class product portfolio, G&H is well positioned to meet the evolving needs of its customers and ensure high quality outcomes for patients. I am excited about the opportunities ahead to serve our customers and accelerate growth.”
Jim O’Brien, G&H board member and Managing Director at Altaris Capital Partners, LLC, added, “We are excited to partner with John as he leads G&H through its next phase of growth, delivering high quality orthodontic solutions to doctors and patients around the world.”
About G&H Orthodontics
G&H Orthodontics, Inc. is a leading provider of clinical solutions for the orthodontic community serving customers for over 40 years in over 90 countries. G&H® is the manufacturer of a full line made in the U.S.A. including brackets, bands, tubes, wires, springs, elastomerics, and other orthodontic supplies. G&H is compliant with the U.S. FDA, ISO 13485:2003, Medical Device Directives, 93/42 EEC and Canadian Medical Device Guidelines, which ensures availability of products worldwide. G&H Orthodontics is a privately held company headquartered in Franklin, Indiana.

Innovative Approach Establishes Blueprint for Medical Device Security Programs to Help Protect Patients from Cybersecurity Threats and Vulnerabilities.
NASHVILLE, Tenn.—(BUSINESS WIRE)—Clearwater and CyberMDX have entered into a partnership to simplify and automate the identification, inventorying, assessment and risk analysis of networked medical devices, using Clearwater’s IRM|ProTM—an Enterprise Cyber Risk Management Software—and CyberMDX’s MDefend—a visibility and cybersecurity solution, powered by an AI and DPI engine, coupled with Clearwater’s professional services.
The CyberMDX-Clearwater joint delivery model—being demonstrated this week at the H-ISAC Fall Summit in San Antonio, TX, Booth 46—creates the most comprehensive and robust enterprise cyber risk management solution available on the market at a time when growing internal and external security threats have made it increasingly difficult for healthcare organizations to protect their sensitive information, including patients’ personal health information (CHIME HealthCare’s Most Wired: National Trends 2018).
“One of the weakest links within clinical networks is also their most critical asset: their connected medical devices,” said CyberMDX Co-Founder and CEO Amir Magner. “Healthcare providers rely on connected medical devices for their clinical workflows and life-saving treatments, but unlike other IT assets, connected medical devices are extremely vulnerable and often poorly managed. Organizations struggle to do a true, enterprise, OCR-quality risk analysis—one that is an information assets-based risk analysis and that evaluates allePHI assets and the specific threats and vulnerabilities that are applicable to them.”
Clearwater CEO Steve Cagle said connected medical devices and other IoT integrated devices or equipment are not just a technology risk but a patient safety risk and a risk to business.
“The truth is, if you don’t know where your devices are, you can’t secure them, and until recently there weren’t good or efficient ways of getting that information,” Cagle said. “Until now, it’s also been difficult to categorize the different groups of like devices to make the risk analysis process more manageable. It’s a tremendous challenge for the industry, and we are pleased to partner with CyberMDX to deliver a best-in-class solution.”
With the CyberMDX-Clearwater joint delivery model, healthcare provider organizations can do in a few hours what has historically taken weeks or months to accomplish. CyberMDX’s unique technology identifies in real-time medical device profile information, which is used by Clearwater to identify like devices from a risk perspective. As a recent deployment for a large Integrated Delivery Network provider showed, the solution was able to condense about 30,000 connected medical devices into about 300 groups by putting them into appropriate classifications and groupings, allowing for a much more manageable risk analysis and ongoing identification, assessment, detection and automatic micro-segmentation of all medical and clinical assets.
Tailored to meet the demanding and unique cybersecurity and HIPAA compliance needs of clinical networks and protocols, CyberMDX’s solution provides an automatic and continuous discovery and profiling solution that is easily deployed, fully scalable and built for large distributed networks.
Clearwater’s IRM|Analysis™ software utilizes the resulting inventory and Clearwater’s proprietary algorithms to facilitate an OCR-Quality Security Risk Analysis on the medical devices, as well as to implement and document remediation actions. The result is a complete risk analysis and risk response solution that complies with HIPAA requirements and can be used to satisfy information request from the Office For Civil Rights (OCR).
“From everything we are seeing with our customers, medical devices are one of their weakest links in the security chain and their greatest concern,” Clearwater’s Cagle said. “In a recent webinar provided by Clearwater and CyberMDX fewer than 18% of attendees stated that they had a comprehensive medical device security program in place.
A compromise of medical devices can have devastating effects for a healthcare provider, including:
the shut down of hospital operations or key functions of a facility
risking patients’ lives by compromising the integrity of data
a back door into the network, resulting in significant data breach of ePHI
the control of devices in critical departments or patient care, e.g. neonatal units and infusion pumps
About CyberMDX
CyberMDX, a pioneer of medical cyber security, delivers zero touch visibility and threat prevention for medical devices and clinical assets. CyberMDX delivers a scalable, easy to deploy cyber security solution, providing unmatched visibility and protection of medical devices ensuring their operational continuity as well as patient and data safety. For more information, please visit us at www.cybermdx.com.
About Clearwater
Clearwater provides the most complete and trusted, enterprise-class cyber risk management solution available. Designed for healthcare providers and their partners, Clearwater’s IRM|Pro™ platform and experienced professional services team provide insights and actions to address compliance, cyber and patient safety risks. Clearwater is a 2017 Inc. 5000 fastest-growing company, the 2018 Best in KLAS winner in Cybersecurity Advisory Services, the 2017 and 2018 Black Book Marketing Research winner in Compliance and Risk Management Solutions, and exclusively endorsed by the American Hospital Association as well as numerous state hospital associations. Clearwater solutions have been deployed within hundreds of hospitals and health systems, Fortune 100 organizations, and federal government institutions. More information about Clearwater is at clearwatercompliance.com.

When urologist Eric Giesler, MD opted to use the Endocare^® Cryocare^® cryotherapy system to treat his patients’ prostate cancer, he had two vendor choices “and this, in my opinion, is the better one.”
Also better: the technologist support he gets when he uses the system to treat about 30 patients annually at four Austin-area hospitals.
“HealthTronics technologists are pretty important,” said Dr. Giesler, a Urology Austin general provider with a focus on urologic oncology. “They’re looking out for any potential missteps. If you forget something, they’re invaluable as a secondary check.”
A technologist shows up at the hospital with the cryotherapy system under arrangements Dr. Giesler has with HealthTronics. It’s a helpful, extra convenience to go along with Endocare^® cryotherapy’s “versatile technology that allows you to treat prostate cancer very precisely,” Dr. Geisler said.
He has built a proven record of success utilizing the system since 2014 – to the point where colleagues in the 42-provider Urology Austin group regularly refer their patients to him for “freezing” prostate tumors. The process is natural, nontoxic and low-impact for high-risk and weaker patients not suited for surgery or radiation therapy.
It also can be used for “salvage cryotherapy,” which is effective in the 20-30 percent of patients where radiation is ineffective. This Endocare^® system also is being used more commonly for interventional oncology treatment of cancer cells in lungs and kidneys, as well as on liver metastases and in palliative interventions (including managing pain from metastatic cancer).